Podophyllotoxin derivatives
Etoposide
The FDA lists this product in 15 strengths and forms.
Composition
- Active ingredients
- ETOPOSIDE 20MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ETOPOSIDE 20MG/ML · InjectableThis page
- ETOPOSIDE 20MG/ML · InjectableANDA203507-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA074351-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA074227-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA074290-001 · Prescription
- ETOPOSIDE 20MG/ML · InjectableANDA074510-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA074513-001 · Prescription
- ETOPOSIDE 20MG/ML · InjectableANDA074968-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA204927-001 · Discontinued
- ETOPOSIDE 20MG/ML · InjectableANDA074529-001 · Prescription
- ETOPOSIDE 20MG/ML · InjectableANDA074813-001 · Discontinued
- ETOPOSIDE 50MG · CapsuleANDA075635-001 · Prescription
- ETOPOSIDE 20MG/ML · InjectableANDA074284-001 · Discontinued
- ETOPOSIDE 20MG/ML · Injectable
At a glance
- Brand name
- Etoposide
- Drug class
- Podophyllotoxin derivatives
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hospira
- Status
- Discontinued
- FDA approval
- 30 Aug 1995
- Application
- ANDA074320-001
- RxCUI
- 4179